Veteran operator and investor focused on scaling technology and growth-stage businesses, with hands-on experience in fundraising, strategic partnerships and board governance. Chris Chatto brings a blend of executive operating roles and venture investing, advising management teams on go-to-market, capital strategy and exits. Active in private markets and secondary transactions, often sourcing early strategic investors and syndicating rounds.
Veteran operator and investor focused on scaling technology and growth-stage businesses, with hands-on experience in fundraising, strategic partnerships and board governance. Chris Chatto brings a blend of executive operating roles and venture investing, advising management teams on go-to-market, capital strategy and exits. Active in private markets and secondary transactions, often sourcing early strategic investors and syndicating rounds.
Specializes in growth-stage technology investments, combining hands-on operating experience with active venture and secondary market participation to accelerate scale-ups. Employs conviction-led, founder-aligned allocations, prioritizing predictable unit economics, capital-efficient go-to-market strategies and clear exit paths. Prefers concentrated, stage-focused stakes with board or advisory roles to influence execution, uses syndication to manage risk, and targets 3–7 year horizons with disciplined follow-on reserves and outcome-oriented governance.
Specializes in growth-stage technology investments, combining hands-on operating experience with active venture and secondary market participation to accelerate scale-ups. Employs conviction-led, founder-aligned allocations, prioritizing predictable unit economics, capital-efficient go-to-market strategies and clear exit paths. Prefers concentrated, stage-focused stakes with board or advisory roles to influence execution, uses syndication to manage risk, and targets 3–7 year horizons with disciplined follow-on reserves and outcome-oriented governance.
| Trades 2010 | Longs Won 1270/2010 63% | Profit Factor 3.78 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $250,392.33 |
| Average Win $107,946.22 | Best Trade (Oct 15) $3.88M | Sharpe Ratio -17.89 |
| Average Loss -$49,045.86 | Worst Trade (Oct 16) -$2.13M | Z-Score -0.32 (24.93%) |
| Commissions $0 | Avg. Trade Length 10m 2w 4d | Expectancy $50,148.14 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 13,889 | 12,500 | 11,111 | 9,722 | 8,333 | 6,944 | 5,556 | 4,167 | 2,778 | 1,389 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 24,064 | $5.83M | $8.3M | - | $2.47M | 42.26% | +0.855% |
ABBV AbbVie Inc. | 1,118 | $221,334.89 | $317,836.22 | - | $96,501.33 | 43.6% | +0.314% |
ABT Abbott Laboratories | 2,631 | $296,394.85 | $274,650.09 | - | -$21,744.76 | -7.34% | -0.277% |
ACGL Arch Capital Group Ltd | 7,275 | $706,112 | $730,919.25 | - | $24,807.25 | 3.51% | +1.168% |
ACHR Archer Aviation Inc. | 29,750 | $167,012.65 | $122,123.75 | - | -$44,888.9 | -26.88% | -3.864% |
ACP abrdn Income Credit Strategies Fund | 11,689 | $69,543.57 | $51,022.48 | - | -$18,521.09 | -26.63% | +0.345% |
ACVF American Conservative Values ETF | 44,966 | $2.13M | $2.49M | - | $357,314.75 | 16.77% | +0.152% |
ADI Analog Devices, Inc. | 823 | $264,732.5 | $336,137.89 | - | $71,405.39 | 26.97% | +1.109% |
AER AerCap Holdings N.V. | 4,738 | $649,560.48 | $692,932.5 | - | $43,372.02 | 6.68% | +0.226% |
AFL Aflac Inc. | 10,679 | $896,674.24 | $1.27M | - | $372,204.54 | 41.51% | +0.652% |
AFRM Affirm Holdings, Inc. | 8,515 | $694,398 | $641,009.2 | - | -$53,388.8 | -7.69% | -0.843% |
AGOX Adaptive Alpha Opportunities ETF | 5,982 | $207,355 | $195,052.68 | - | -$12,302.32 | -5.93% | -0.696% |
AMAX Adaptive Hedged Multi-Asset Income ETF | 400,421 | $3.2M | $2.97M | - | -$228,579.64 | -7.14% | -0.603% |
AMD Advanced Micro Devices, Inc. | 2,047 | $558,736.78 | $1.11M | - | $550,900.98 | 98.6% | -3.584% |
AMGN Amgen Inc. | 682 | $223,539.08 | $296,758.66 | - | $73,219.58 | 32.75% | +0.253% |
AMZN Amazon.com Inc | 13,642 | $2.58M | $3.46M | - | $878,215.49 | 34.08% | -0.587% |
ARM Arm Holdings plc American Depositary Receipt | 634 | $224,797 | $149,262.62 | - | -$75,534.38 | -33.6% | -3.824% |
AVGO Broadcom Inc. | 690 | $213,545.26 | $230,715.3 | - | $17,170.04 | 8.04% | -2.893% |
AVK Advent Convertible and Income Fund | 14,547 | $171,062.27 | $158,853.24 | - | -$12,209.03 | -7.14% | -1.975% |
AZN AstraZeneca PLC American Depositary Shares | 1,482 | $291,824.21 | $245,078.34 | - | -$46,745.87 | -16.02% | -0.786% |